NCT06157580View on ClinicalTrials.gov

Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 8, 2023

Primary Completion Date

October 24, 2024

Study Completion Date

December 10, 2024

Conditions
Preeclampsia
Interventions
DRUG

Compound 21

differences in vasodilation to compound 21 in the skin between groups

DRUG

Angiotensin II

differences in vasoconstriction to angiotensin II in the skin between groups

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
lead

Anna Stanhewicz, PhD

OTHER

NCT06157580 - Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia | Biotech Hunter | Biotech Hunter